Enhanced Delivery and Antitumor Effect of Doxorubicin Encapsulated in Long-Circulating Liposomes

References

• Gabizon A., Meshorer A., Barenholz Y. Comparative long-term study of the toxicities of free and liposome-associated doxorubicin in mice after intravenous administration. J. Natl. Cancer Inst 1986; 77: 459
   PubMed Web of Science ®Google Scholar
• Ostro M.J. Liposomes from Biophysics to Therapeutics. Marcel Dekker, New York 1987
   Google Scholar
• Poste G., Bucana C., Raz A., Bugelski P., Kirsh R., Fidler I.J. Analysis of the fate of systematically administered liposomes and implications for their use in drug delivery. Cancer Res. 1982; 42: 1412
   PubMed Web of Science ®Google Scholar
• Hwang K.J. Liposome Pharmacokinetics. “Liposome from biophysics to therapeutics.”, M.J. Ostro. Maecel Dekker Inc., New York 1987; 109
   Google Scholar
• Allen T.M., Chonn A. Large unilamellar liposomes with low uptake into the reticuloendothelial system. FEBS Lett. 1987; 223: 42
   PubMed Web of Science ®Google Scholar
• Allen T.M., Hansen C., Rutledge J. Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial system and other tissues. Biochim. Biophys. Acta 1989; 981: 27
   PubMed Web of Science ®Google Scholar
• Gabizon A., Papahadjopoulos D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc. Natl. Acad. Sci. USA 1988; 85: 6949
   PubMed Web of Science ®Google Scholar
• Gabizon A., Price D.C., Huberty J., Bresalier R.S., Papahadjopoulos D. Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: biodistribution and imaging studies. Cancer Res. 1990; 50: 6371
   PubMed Web of Science ®Google Scholar
• Klibanov A.L., Maruyama K., Torchilin V.P., Huang L. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett 1990; 268: 235
   PubMed Web of Science ®Google Scholar
• Klibanov A.L., Maruyama K., Beckerleg A.M., Torchilin V.P., Huang L. Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. Biochim. Biophys. Acta 1991; 1062: 142
   Google Scholar
• Maruyama K., Yuda T., Okamoto A., Ishikura C., Kojima S., Iwatsuru M. Effect of molecular weight in amphipathic polyethyleneglycol on prolonging the circulation time of large unilamellar liposomes. Chem. Pharm. Bull. 1991; 39: 1620
   PubMed Web of Science ®Google Scholar
• Maruyama K., Yuda T., Okamoto A., Kojima S., Suginaka A., Iwatsuru M. Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol). Biochim. Biophys. Acta 1992; 1128: 44
   Google Scholar
• Blume G., Cevec G. Liposomes for sustained drug release in vivo. Biochim Biophys. Acta 1990; 1029: 91
   PubMed Web of Science ®Google Scholar
• Allen T.M., Hansen C., Martin F., Redemann C., Young A.Y. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim. Biophys. Acta 1991; 1066: 29
   Google Scholar
• Young R.C., Ozols R.F., Myers C.E. The anthracycline antineoplastic drugs. N. Engl. J. Med. 1981; 305: 139
   PubMed Web of Science ®Google Scholar
• Wang J.J., Cortes E., Sinks L.F., Holland J.F. Therapeutic effect and toxicity of adriamycin in patients with neoplastic disease. Cancer 1971; 28: 837
   PubMed Web of Science ®Google Scholar
• Rahman A., Kessler A., More N., Sikic B., Rowden G., Woolley P., Schein P. S. Liposomal protection of adriamycin-induced cardiotoxicity in mice. Cancer Res. 1980; 40: 1532
   PubMed Web of Science ®Google Scholar
• Olson F., Mayhew E., Maslow D., Rustum Y., Szoka F. Characterization, toxicity, and therapeutic efficacy of adriamycin encapsulated in liposomes. Eur. J. Cancer Clin. Oncol. 1982; 18: 167
   PubMedGoogle Scholar
• Maruyama K., Okamoto A., Ishida O., Kojima S., Suginaka A., Huang L., Iwatsuru M. Biodistribution and antitumor effect of adriamycin encapsulated in long-circulating liposomes containing amphipathic polyethyleneglycol or ganglioside GM1 (submitted). 1993
   Google Scholar
• Unezaki S., Maruyama K., Ishida O., Takahashi N., Iwatsuru M. Enhanced tumor targeting of doxorubicin by ganglioside GM1-bearing long-circulating liposomes (submitted). 1993
   Google Scholar
• Unezaki S., Maruyama K., Ishida O., Suginaka A., Takahashi N., Iwatsuru M. Enhanced tumor targeting and improved antitumor activity of doxorubicin by long-circulating liposomes containing amphipathic poly(ethylene glycol) (submitted). 1993
   Google Scholar
• Maruyama K., Unezaki S., Takahashi N., Iwatsuru M. Enhanced delivery of doxorubicin to tumor by long-circulating thermosensitive liposomes and local hyperthermia. Biochim. Biophys. Acta 1993, (in press)
   Google Scholar
• Sommerman E.F., Pritchard P.H., Cullis P.R. 125I labelled inulin.: A convenient marker for deposition of liposomal contents in vivo. Biochem. Biophys. Res. Commun. 1984; 122: 319
   PubMed Web of Science ®Google Scholar
• Ogihara I., Kojima S., Jay M. Tumor uptake of 67Ga-carrying liposomes. Eur. J. Nucl. Med. 1986; 11: 405
   PubMedGoogle Scholar
• Szoka F., Papahadjopoulos D. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc. Natl. Acad. Sci. USA 1978; 75: 4194
   PubMed Web of Science ®Google Scholar
• Mayer L.D., Bally M.B., Hope M.J., Cullis P.R. Uptake of antineoplastic agents into large unilamellar vesicles in response to membrane potential. Biochim. Biophys. Acta 1985; 816: 294
   PubMed Web of Science ®Google Scholar
• Wu M.S., Robbins J.C., Bugianesi R.L., Ponpipom M.M., Shen T.Y. Modified in vivo behavior of liposomes containing synthetic glycolipids. Biochim. Biophys. Acta 1981; 674: 19
   PubMed Web of Science ®Google Scholar
• Masuike J., Odake J., Kohagura M., Noda T., Takemoto T. Determination of adriamycin and its metabolites in biological samples using high performance liquid chromatography. II) Analysis of tissues by extraction method. Yakugaku Zasshi (Japanese) 1984; 104: 620
   PubMed Web of Science ®Google Scholar
• Druckmann S., Gabizon A., Barenholz A. Separation of liposome-associated doxorubicin from non-liposome-associated doxorubicin in human plasma: implications for pharmacokinetics studies. Biochim. Biophys. Acta 1989; 980: 381
   Google Scholar
• Senior J., Delgado C., Fisher D., Tilcock C., Gregoriadis G. Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly (ethylene glycol)-coated vesicles. Biochim. Biophys. Acta 1991; 1062: 77
   Google Scholar
• Mori A., Klibanov A.L., Torchilin V.P., Huang L. Influence of the steric barrier activity of amphipathic poly (ethylene glycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo. FEBS Lett. 1991; 284: 263
   PubMed Web of Science ®Google Scholar
• Jain R.K., Gerlowski L.E. Extravascular transport in normal and tumor tissue. Crit Rev. Oncol. Hematol. 1986; 5: 115
   PubMed Web of Science ®Google Scholar
• Kaplan H.M., Brewer N.R., Blair W.H. “The Mouse in Biomedical Research.”, H.L. Foster, J.D. Small, J.G. Fox. Academic Press, New York 1983; 248, Chap. 11
   Google Scholar